Skip to main content

Advertisement

SpringerLink
Log in

Apoptosis, angiogenesis, inflammation, and oxidative stress: basic interactions in patients with early and metastatic breast cancer

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Breast cancer (BC) is a complex, multi-stage disease involving deregulation of different signaling cascades. The present study was conducted to determine the extent of apoptosis, angiogenesis, inflammation, and oxidative stress in patients with different stages of BC as an approach to disease biological behavior. Therefore, plasma levels of soluble (s) Fas, bcl-2 as antiapoptotic indices; interleukin (IL)-8, tumor necrosis factor (TNF)-α as apoptotic, inflammatory, angiogenic indices; lipid peroxides (LPO), nitric oxide (NO) as oxidative stress and angiogenic indices were measured in patients with BC.

Methods

Thirty-seven newly diagnosed patients with BC, 30 patients with benign breast masses, and 30 healthy controls were recruited. Plasma levels of sFas, bcl-2, IL-8, and TNF-α were measured by immunosorbent assay kits and LPO and NO by chemical methods.

Results

Plasma sFas and LPO were significantly higher in BC patients versus benign breast masses and healthy controls (P < 0.0001). Bcl-2, IL-8, TNF-α, and NO were significantly higher in benign breast masses (P < 0.0001, P < 0.037, P < 0.0001, P < 0.001) and BC (P < 0.0001) versus controls and in BC versus benign breast masses (P < 0.0001). sFas, bcl-2, IL-8, TNF-α, LPO, and NO were increased with advanced tumor stages. There were positive correlations between sFas, bcl-2, IL-8 TNF-α, LPO, and NO.

Conclusions

BC tumor cells overexpress bcl-2 and sFas to secure their outgrowth and survival. However, this coincides with activation of physiologic regulatory mechanisms, as increased IL-8, TNF-α, LPO, and NO, which try to stop tumor cells by inducing apoptosis. Outcompeting of these mechanisms result in tumor progression as IL-8, TNF-α, and NO are also angiogenic stimulators.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Balbay MD, Pettaway CA, Kuniyasu H, Inoue K, Ramirez E, Li E, Fidler IJ, Dinney CP (1999) Highly metastatic human prostate cancer growing within the prostate of athymic mice over expresses vascular endothelial growth factor. Clin Cancer Res 5:783–789

    PubMed  CAS  Google Scholar 

  • Balkwill F (2002) Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev 13:135–141

    Article  PubMed  CAS  Google Scholar 

  • Benoy IH, Salgado R, Van Dam P, Geboers K, Van Marck E, Scharpé S, Vermeulen PB, Dirix LY (2004) Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin Cancer Res 10:7157–7162

    Article  PubMed  CAS  Google Scholar 

  • Bukholm IK, Nesland JM, Karesn R, Jacobsen U, Borresendale AL (1997) Interaction between bcl-2 and p21 (WAF1/CIP1) in breast carcinomas with wild-type p53. Int J Cancer 73:38–41

    Article  PubMed  CAS  Google Scholar 

  • De Larco JE, Wuertz BR, Yee D, Rickert BL, Furcht LT (2003) Atypical methylation of the interleukin-8 gene correlates strongly with the metastatic potential of breast carcinoma cells. Proc Natl Acad Sci USA 100:13988–13993

    Article  PubMed  Google Scholar 

  • Ding AH, Nathan CF, Stuchr DJ (1988) Release of reactive nitrogen intermediate from mouse peritoneal macrophage comparison of activating cytokines and evidence for independent production. J Immuno 141(7):2407–2412

    CAS  Google Scholar 

  • Donato NJ, Klostergaard J (2004) Distinct stress and cell destruction pathways are engaged by TNF and ceramide during apoptosis of MCF-7 cells. Exp Cell Res 294:523–533

    Article  PubMed  CAS  Google Scholar 

  • Donskov F, Hokland M, Marcussen N, Torp Madsen HH, von der Maase H (2006) Monocytes and neutrophils as ‘bad guys’ for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma-results from a randomized phase II trial. Br J Cancer 94:218–226

    Article  PubMed  CAS  Google Scholar 

  • Gaballah HE, Abdel Salam I, Abdel Wahab N, Mansour OM (2001) Plasma bcl-2 and nitric oxide: possible prognostic role in patients with metastatic breast cancer. Med Oncol 18:171–178

    Article  PubMed  CAS  Google Scholar 

  • Geller DA, Billiar TR (1998) Molecular biology of nitric oxide synthases. Cancer Metastasis Rev 17(1):7–23

    Article  PubMed  CAS  Google Scholar 

  • Gönenç A, Erten D, Aslan S, Akinci M, Simşek B, Torun M (2006) Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease. Cell Biol Int 30(4):376–380

    Article  PubMed  Google Scholar 

  • Gong Y, Sun X, Huo L (2005) Expression of cell adhesion molecules, CIM 4 s and Ecadherin, and microvessel density in invasive micropapillary carcinoma of the breast. Histopathology 46(1):24–30

    Article  PubMed  CAS  Google Scholar 

  • Grau A, Codony R, Rafecas M, Barroeta AC, Guardiola F (2000) Lipid hydroperoxide determination in dark chicken meat through a ferrous oxidation-xylenol orange method. J Agric Food Chem 48(9):4136–4143

    Article  PubMed  CAS  Google Scholar 

  • Hagemann T, Wilson J, Kulbe H, Li NF, Leinster DA, Charles K, Klemm F, Pukrop T, Binder C, Balkwill FR (2005) Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. Immunology 175(2):1197–1205

    CAS  Google Scholar 

  • Haklar G, Sayin-Ozveri E, Yüksel M, Aktan AO, Yalçin AS (2001) Different kinds of reactive oxygen and nitrogen species were detected in colon and breast tumors. Cancer Lett 165(2):219–224

    Article  PubMed  CAS  Google Scholar 

  • Jalava PJ, Collan YU, Kuopio T, Juntti-Patinen L, Kronqvist P (2000) Bcl-2 immunostaining: a way to finding unresponsive postmenopausal N+ breast cancer patients. Anticancer Res 20(2B):1213–1219

    PubMed  CAS  Google Scholar 

  • Jang J-H, Surh Y-J (2003) Potentiation of cellular antioxidant capacity by Bcl-2: implications for its antiapoptotic function. Biochem Pharmacol 66:1371–1379

    Article  PubMed  CAS  Google Scholar 

  • Karin M (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441:431–436

    Article  PubMed  CAS  Google Scholar 

  • Khanzode SS, Muddeshwar MG, Khanzode SD, Dakhale GN (2004) Antioxidant enzymes and lipid peroxidation in different stages of breast cancer. Free Radic Res 38:81–85

    Article  PubMed  CAS  Google Scholar 

  • Kinipping E, Debatin KM, Stricker K, Heilig B, Eder A, Krammer PH (1995) Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemia. Blood 85:1562–1569

    Google Scholar 

  • Kozlowski L, Zakrzewska I, Tokajuk P, Wojtukiewicz MZ (2003) Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients. Rocz Akad Med Bialymst 48:82–84

    PubMed  CAS  Google Scholar 

  • Lala PK, Orucevic A (1998) Role of nitric oxide in tumor progression: lessons from experimental tumors. Cancer Metastasis Rev 17(1):91–106

    Article  PubMed  CAS  Google Scholar 

  • Lang K, Niggeman B, Zanker K, Entschladen F (2002) Signal processing of migrating T24 human bladder carcinoma cells: role of the autocrine interleukin-8. Int J Cancer 99:673–680

    Article  PubMed  CAS  Google Scholar 

  • Lee LF, Hellendall RP, Wang Y, Haskill JS, Mukaida N, Matsushima K, Ting JP (2000) IL-8 reduced tumorigenicity of human ovarian cancer in vivo due to neutrophil infiltration. J Immunol 164:2769–2775

    PubMed  CAS  Google Scholar 

  • Lee M, Hyun DH, Marshall KA, Ellerby LM, Bredesen DE, Jenner P, Halliwell B (2001) Effect of overexpression of BCL-2 on cellular oxidative damage, nitric oxide production, antioxidant defenses, and the proteasome. Free Radic Biol Med 31(12):1550–1559

    Article  PubMed  CAS  Google Scholar 

  • Lin Y, Huang R, Chen L, Li S, Shi Q, Jordan C, Huang RP (2004) Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int J Cancer 109(4):507–515

    Article  PubMed  CAS  Google Scholar 

  • Liu CY, Wang CH, Chen TC, Lin HC, Yu CT, Kuo HP (1998) Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer. Br J Cancer 78(4):534–541

    Article  PubMed  CAS  Google Scholar 

  • McDonnell TJ, Korsmeyer SJ (1991) Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature 349:254–256

    Article  PubMed  CAS  Google Scholar 

  • Mortensen K, Holck S, Christensen IJ, Skouv J, Hougaard DM, Blom J, Larsson LI (1999) Endothelial cell nitric oxide synthase in peritumoral microvessels is a favorable prognostic indicator in premenopausal breast cancer patients. Clin Cancer Res 5(5):1093–1097

    PubMed  CAS  Google Scholar 

  • Nahta R, Esteva FJ (2003) Bcl-2 antisense oligonucleotides: a potential novel strategy for the treatment of breast cancer. Semin Oncol 30:143–149

    Article  PubMed  CAS  Google Scholar 

  • Natoli G, Ianni A, Costanzo A, Petrillo GD, Ilari I, Chirillo P, Balsano C, Levrero M (1995) Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene 11:1157–1164

    PubMed  CAS  Google Scholar 

  • Niwa Y, Akamatsu H, Niwa H, Sumi H, Ozaki Y, Abe A (2001) Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res 7:285–289

    PubMed  CAS  Google Scholar 

  • Pietenpol JA, Papadopoulos N, Markowitz S, Willson JK, Kinzler KW, Vogelstein B (1994) Paradoxical inhibition of solid tumor cell growth by bcl2. Cancer Res 54:3714–3717

    PubMed  CAS  Google Scholar 

  • Portakal O, Ozkaya O, Erden Inal M, Bozan B, Koşan M, Sayek I (2000) Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. Clin Biochem 33:279–284

    Article  PubMed  CAS  Google Scholar 

  • Rajneesh CP, Manimaran A, Sasikala KR, Adaikappan P (2008) Lipid peroxidation and antioxidant status in patients with breast cancer. Singap Med J 49(8):640

    CAS  Google Scholar 

  • Sahebari M, Hatef MR, Rezaieyazdi Z, Abbasi M, Abbasi B, Mahmoudi M (2010) Correlation between serum levels of soluble Fas (CD95/Apo-1) with Disease Activity in Systemic Lupus Erythematosus Patients in Khorasan, Iran. Arch Iran Med 13(2):135–142

    PubMed  CAS  Google Scholar 

  • Sheen-Chen SM, Chen WJ, Eng HL, Chou FF (1997) Serum concentration of tumor necrosis factor in patients with breast cancer. Breast Cancer Res Treat 43:211–215

    Article  PubMed  CAS  Google Scholar 

  • Sheen-Chen SM, Chen HS, Eng HL, Chen WJ (2003) Circulating soluble Fas in patients with breast cancer. World J Surg 27:10–13

    Article  PubMed  Google Scholar 

  • Suhendan E, Tang CH, Elizabeth AG (2005) NO news is not necessarily good news in cancer. Curr Cancer Drug Targets 5:103–115

    Article  Google Scholar 

  • Szlosarek PW, Balkwill FR (2003) Tumor necrosis factor alpha: a potential target for the therapy of solid tumors. Lancet Oncol 4(9):565–573

    Article  PubMed  CAS  Google Scholar 

  • Thomadaki H, Scorilas A (2008) Molecular profile of the BCL-2 family of the apoptosis related genes in breast cancer cells after treatment with cytotoxic/cytostatic drugs. Connect Tissue Res 49:261–264

    Article  PubMed  CAS  Google Scholar 

  • Thomsen LL, Miles DW, Happerfield LC, Bobrow LG, Knowles RG, Moncada S (1995) Nitric oxide synthase activity in human breast cancer. Br J Cancer 72:41–44

    Article  PubMed  CAS  Google Scholar 

  • Thorburn A (2004) Death receptor-induced cell killing. Cell Signal 16:139–144

    Article  PubMed  CAS  Google Scholar 

  • Uchara T, Kikuchi Y, Nonura Y (1999) Caspase activation accompanying cytochrome C release from mitochondria is possibly involved in nitric oxide-induced neuronal apoptosis in SH-SY5Y cells. J Neurochem 72:196–205

    Google Scholar 

  • Ueno T, Toi M, Tominaga T (1999) Circulating soluble Fas concentration in breast cancer patients. Clin Cancer Res 5:3529–3533

    PubMed  CAS  Google Scholar 

  • Van Slooten HJ, Van de Vijiver MJ, Van de Velde CJ, van Dierendonck JH (1998) Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity. Br J Cancer 77(5):789–796

    Article  PubMed  Google Scholar 

  • Vargas-Roig LM, Cuello-Carrion FD, Fernandez-Escobar N, Daguerre P, Leuzzi M, Ibarra J, Gago FE, Nadin SB, Ciocca DR (2008) Prognostic value of Bcl-2 in breast cancer patients treated with neoadjuvant anthracycline based chemotherapy. Mol Oncol 2:102–111

    Article  PubMed  Google Scholar 

  • Xie K, Fidler IJ (1998) Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metastasis Rev 17(1):55–75

    Article  PubMed  CAS  Google Scholar 

  • Yang Q, Moran MS, Haffty BG (2009) Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapy. Breast Cancer Res Treat 115:343–348

    Article  PubMed  CAS  Google Scholar 

  • Zhao X, Sun X, Gao F, Luo J, Sun Z (2011) Effects of ulinastatin and docataxel on breast tumor growth and expression of IL-6, IL-8, and TNF-alpha. J Exp Clin Cancer Res 30:22

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The author(s) declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Physiology, Faculty of Medicine, Assiut University, P.O. Box: 71526, Assiut, Egypt

    Enas A. Hamed

  2. Department of Biochemistry, Faculty of Medicine, Assiut University, Assiut, Egypt

    Madeha M. Zakhary

  3. Department of Surgical Oncology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt

    Doaa W. Maximous

Authors
  1. Enas A. Hamed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Madeha M. Zakhary
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Doaa W. Maximous
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Enas A. Hamed.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hamed, E.A., Zakhary, M.M. & Maximous, D.W. Apoptosis, angiogenesis, inflammation, and oxidative stress: basic interactions in patients with early and metastatic breast cancer. J Cancer Res Clin Oncol 138, 999–1009 (2012). https://doi.org/10.1007/s00432-012-1176-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-012-1176-4

Keywords

Search

Navigation